You are here

Daiichi Sankyo

Merck advances lung cancer attack, pocketing $170M from Daiichi and plotting ADC-trispecific combo

Fierce Biotech

Tue, 08/6/24 - 11:20 am

Harpoon Therapeutics

small cell lung cancer

Daiichi Sankyo and MSD announce first subject dosing in lung cancer trial

Clinical Trials Arena

Fri, 08/2/24 - 11:50 am

clinical trials

small cell lung cancer

After tense standoff, AstraZeneca and Daiichi's Enhertu turned away by NICE on pricing grounds

Fierce Pharma

Mon, 07/29/24 - 10:51 am

HER2-low breast cancer

Daiichi Sankyo Wins $47M in ADC Patent Arbitration With Seagen, Pfizer Dispute Looms

BioSpace

Mon, 07/1/24 - 11:14 am

FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug

Reuters

Thu, 06/27/24 - 11:18 am

patritumab deruxtecan

antibody-drug conjugate

5 FDA Decisions to Watch in the Second Half of 2024

BioSpace

Mon, 06/24/24 - 11:29 am

Alzheimer's disease

advanced synovial sarcoma

Lykos Therapeutics

Bristol Myers Squibb

non-small cell lung cancer

ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer

Fierce Pharma

Sun, 06/2/24 - 02:46 pm

The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel

Pharma Voice

Fri, 05/10/24 - 11:12 am

AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial

Clinical Trials Arena

Mon, 04/29/24 - 11:12 am

HER2-low breast cancer

FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers

Investing.com

Sun, 04/7/24 - 04:45 pm

Daiichi Sankyo and Merck dose first subject in ovarian cancer trial

Clinical Trials Arena

Thu, 04/4/24 - 10:53 am

clinical trials

raludotatug deruxtecan

AZ, Daiichi Sankyo file Dato-DXd for second indication

Pharmaphorum

Tue, 04/2/24 - 11:31 am

Surprise Enhertu rejection follows NICE process change

Pharmaphorum

Tue, 03/5/24 - 11:35 am

HER2-low breast cancer

Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review

Clinical Trials Arena

Tue, 02/20/24 - 11:30 am

non-small cell lung cancer

Daiichi invests 1 bln eur near Munich to make precision cancer drugs

Reuters

Fri, 02/16/24 - 11:51 am

precision medicine

Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC

Fierce Pharma

Wed, 01/31/24 - 10:27 pm

AstraZeneca, Daiichi aim for first pan-tumor ADC approval

BioPharma Dive

Mon, 01/29/24 - 11:25 am

antibody-drug conjugate

BioNTech challenges AstraZeneca with breast cancer precision drug trial

Reuters

Mon, 01/22/24 - 11:15 am

Duality Biologics

clinical trials

HER2+ breast cancer

Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News

Pharmaphorum

Wed, 01/17/24 - 09:38 am

Pages